PSNL

Personalis (PSNL)

Personalis Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PSNL

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2022/06/07	06:30	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/05/20	08:51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/05/20	08:46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/05/20	08:28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/05/20	08:12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/05/20	08:02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/05/20	05:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PSNL	Personalis Inc
2022/05/19	07:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/05/19	07:16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/05/06	13:45	TipRanks	Analysts Offer Insights on Healthcare Companies: 1Life Healthcare (ONEM), 89bio (ETNB) and Personalis (PSNL)	NASDAQ:PSNL	Personalis Inc
2022/05/05	19:45	TipRanks	Needham Keeps Their Hold Rating on Personalis (PSNL)	NASDAQ:PSNL	Personalis Inc
2022/05/05	19:27	TipRanks	H.C. Wainwright Keeps Their Buy Rating on Personalis (PSNL)	NASDAQ:PSNL	Personalis Inc
2022/05/05	06:39	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PSNL	Personalis Inc
2022/05/05	05:44	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:PSNL	Personalis Inc
2022/05/05	05:15	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PSNL	Personalis Inc
2022/05/05	05:03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PSNL	Personalis Inc
2022/05/05	05:01	Business Wire	Personalis Reports First Quarter 2022 Financial Results	NASDAQ:PSNL	Personalis Inc
2022/04/29	05:01	Business Wire	Personalis to Present at Upcoming Investor Conferences	NASDAQ:PSNL	Personalis Inc
2022/04/27	15:09	Business Wire	Evaxion nutzt ImmunoID NeXT Platform® von Personalis zur Untersuchung der Wirksamkeit einer Kombinationstherapie für Melanome in späten Stadien	NASDAQ:PSNL	Personalis Inc
2022/04/27	04:24	Business Wire	Evaxion s’apprête à utiliser l’ImmunoID NeXT Platform® de Personalis pour évaluer l’efficacité d’une thérapie combinée contre le mélanome de stade avancé	NASDAQ:PSNL	Personalis Inc
2022/04/27	00:44	Business Wire	Evaxion userà la ImmunoID NeXT Platform® di Personalis per valutare l’efficacia della sua terapia combinata per il trattamento del melanoma in stadio avanzato	NASDAQ:PSNL	Personalis Inc
2022/04/26	21:45	Business Wire	Evaxion to Utilize Personalis’ ImmunoID NeXT Platform® to Evaluate Efficacy of Combination Therapy for Late-Stage Melanoma	NASDAQ:PSNL	Personalis Inc
2022/04/21	22:00	Business Wire	Personalis Expands Diagnostic Leadership Team With Appointment of James Azzaro, Vice President of Diagnostic Sales	NASDAQ:PSNL	Personalis Inc
2022/04/21	05:01	Business Wire	Personalis to Announce First Quarter 2022 Financial Results	NASDAQ:PSNL	Personalis Inc
2022/04/13	07:55	Business Wire	Personalis publie de nouvelles données prouvant la capacité d’un algorithme hautement sensible à détecter la perte d’hétérozygotie du gène HLA	NASDAQ:PSNL	Personalis Inc
2022/04/13	06:55	Business Wire	Personalis gibt neue Daten preis, die einen hochsensiblen Algorithmus zum Nachweis des Verlusts von Heterozygotie im HLA-Gen aufzeigen	NASDAQ:PSNL	Personalis Inc
2022/04/13	03:10	Business Wire	Personalis pubblica nuovi dati che dimostrano l’elevata sensibilità del suo algoritmo per il rilevamento della perdita di eterozigosi nel gene HLA	NASDAQ:PSNL	Personalis Inc
2022/04/12	21:55	Business Wire	Personalis Publishes New Data Demonstrating Highly Sensitive Algorithm for Detecting Loss of Heterozygosity in HLA Gene	NASDAQ:PSNL	Personalis Inc
2022/04/12	21:30	Business Wire	Personalis Announces Issuance of Additional US Patent Related to the NeXT Personal™ Platform	NASDAQ:PSNL	Personalis Inc
2022/04/12	15:55	Business Wire	Personalis et Merck KGaA, Darmstadt, Germany vont présenter des données complètes concernant leur collaboration sur le sous-typage des tumeurs lors de du Congrès annuel 2022 de l’AACR	NASDAQ:PSNL	Personalis Inc